MGLL and neurodegenerative disease: Previous studies demonstrated that 2-AG or inactivation of MAGL produces anti-inflammatory and neuroprotective effects in vitro and in animal models of neurodegenerative diseases [11–13, 21, 23–28, 39, 60].